Blog

Get the latest perspectives on real world data and evidence.

Claims Data: Consider the Source

Read More

Selecting the Most Relevant Data

Choosing the right data to answer research questions is important, especially when it comes to developing an external control arm. External comparators or controls (also known as historical controls) have the potential to improve the evaluation of novel experimental agents in clinical trials.

Read More

New Brand, New Website!

Read More

Front Lines in Medicine: Healthcare During COVID-19

Read More

Real-World Experience: Data, Evidence, Control Arms and Outcomes

In 2016, the 21st Century Cures Act (Cures Act) directed the Food and Drug Administration (FDA) to accept statistical methods that include Real-World Data (RWD) and Real-World Evidence (RWE). The next year, the Center for Devices and Radiological Health (CDRH) and Center for Biologics Evaluation and Research (CBER) issued guidance regarding the submission of RWD and RWE to the FDA.

Read More

Long COVID: Potential Long-Term Neurological Consequences of the COVID-19 Pandemic

Designated, "Long COVID", there is significant concern over the potential long-term effects among COVID-19 survivors. The most prominent end-organ systems at risk for long-term effects are pulmonary, cardiovascular, and central nervous system (CNS). The CNS effects can result either from primary involvement by COVID, like hyposmia, or risk from secondary morbidity, such as hypercoagulability causing a stroke.

Read More

Sign up to receive communications